SLOUGH, Vereinigtes Königreich, Feb. 03, 2026 (GLOBE NEWSWIRE) — John Crane, ein Unternehmen der Smiths Group plc und ein weltweit führender Anbieter innovativer Lösungen für Rotating Equipment feiert das [...] Read more »
Wohin es Geschäftsreisende 2026 wirklich zieht – laut Holafly
DUBLIN, Irland, Feb. 03, 2026 (GLOBE NEWSWIRE) — Nach dem starken Aufschwung im Jahr 2025 beginnt für Unternehmen nun eine besonnenere Phase der Mobilität. Inzwischen ist klar: Beim Reisen geht es nicht mehr darum, [...] Read more »
Where business travelers are really going in 2026, according to Holafly
DUBLIN, Ireland, Feb. 03, 2026 (GLOBE NEWSWIRE) — After the sharp rebound of 2025, companies are moving into a more deliberate phase of mobility. At this point, everybody knows that travel is no longer about clocking miles or filling [...] Read more »
Destino dos viajantes de negócios em 2026, de acordo com a Holafly
DUBLIN, Irlanda, Feb. 03, 2026 (GLOBE NEWSWIRE) — Após a forte recuperação de 2025, as empresas estão entrando em uma fase mais deliberada de mobilidade. Atualmente todos sabem que viajar não se [...] Read more »
Les véritables destinations des voyageurs d’affaires en 2026, selon Holafly
DUBLIN, Irlande, 03 févr. 2026 (GLOBE NEWSWIRE) — Après le fort rebond de 2025, les entreprises entrent dans une phase plus réfléchie en matière de mobilité professionnelle. Aujourd’hui, [...] Read more »
CGTN: More than a journey: How Spring Festival travel rush reflects a changing China
The 2026 Spring Festival travel rush begins on February 2 and will run for 40 days, ending on March 13. Ahead of this annual migration, CGTN published a feature article exploring how the event has transcended its role as [...] Read more »
Cronos Group Launches Premium Lord Jones® Brand in Israel, Advancing Borderless Product Strategy
TORONTO, Feb. 02, 2026 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON; TSX: CRON) (“Cronos” or the “Company”), a leading global cannabinoid company, today announced the launch of its Lord Jones® [...] Read more »
BitMEX Launches the Grand Ascent Campaign Featuring a 100,000 USDT Prize Pool
VICTORIA, Seychelles, Feb. 02, 2026 (GLOBE NEWSWIRE) — Read more »
EZVIZ breaks new ground in outdoor security with the 4G & Wi-Fi battery camera family, addressing everyday challenges while inspiring new scenarios from homes to wilderness
JOHANNESBURG, Feb. 02, 2026 (GLOBE NEWSWIRE) — EZVIZ, recognized for reshaping the smart security landscape with its pioneering technologies, reinvents a familiar favorite with the debut of its 4G & Wi–Fi [...] Read more »
تُحدث EZVIZ نقلة نوعية في أمن الأماكن الخارجية مع سلسلة كاميرات 4G العاملة بالبطارية، لتواجه تحديات الحياة اليومية وتفتح آفاقًا جديدة للاستخدام من المنازل إلى المناطق البرية
RIYADH, Saudi Arabia, Feb. 02, 2026 (GLOBE NEWSWIRE) —
2026 Read more »
EZVIZ breaks new ground in outdoor security with the 4G & Wi-Fi battery camera family, addressing everyday challenges while inspiring new scenarios from homes to wilderness
RIYADH, Saudi Arabia, Feb. 02, 2026 (GLOBE NEWSWIRE) — EZVIZ, recognized for reshaping the smart security landscape with its pioneering technologies, reinvents a familiar favorite with the debut of its 4G & [...] Read more »
BHP backs the next wave of exploration and technology talent in its biggest Xplor intake yet
MELBOURNE, Australia, Feb. 01, 2026 (GLOBE NEWSWIRE) — BHP has selected 10 early–stage exploration and technology companies for the 2026 BHP Xplor program, marking the largest cohort since the program began and its fourth year [...] Read more »
Kyowa Kirin Recupera Controle do Programa de Desenvolvimento e Comercialização do Rocatinlimab, Demonstrando Forte Compromisso para Abordar a Alta Necessidade Médica Não Atendida na Dermatite Atópica
- A Kyowa Kirin afirma o compromisso de desenvolver o rocatinlimab como um ativo diferenciado de mudança de vida com potencial de mercado significativo.
- Read more »
Kyowa Kirin reprend le contrôle du programme de développement et de commercialisation du rocatinlimab, manifestant ainsi son profond engagement visant à répondre aux besoins médicaux non satisfaits dans le domaine de la dermatite atopique
- Kyowa Kirin réaffirme sa volonté de développer le rocatinlimab comme un traitement innovant capable d’améliorer significativement la vie des patients, tout en [...] Read more »
Kyowa Kirin erlangt Kontrolle über Entwicklungs- und Kommerzialisierungsprogramm für Rocatinlimab wieder, zeigt starkes Engagement im Bereich des ungedeckten medizinischen Bedarfs bei atopischer Dermatitis
- Kyowa Kirin bestätigt Engagement für die Entwicklung von Rocatinlimab als lebensveränderndes differenziertes Feld mit bedeutendem Marktpotenzial.
- Read more »